Avvinity Therapeutics Limited Revenue and Competitors
Estimated Revenue & Valuation
- Avvinity Therapeutics Limited's estimated annual revenue is currently $1.7M per year.
- Avvinity Therapeutics Limited's estimated revenue per employee is $155,000
Employee Data
- Avvinity Therapeutics Limited has 11 Employees.
- Avvinity Therapeutics Limited grew their employee count by -8% last year.
Avvinity Therapeutics Limited's People
Name | Title | Email/Phone |
---|
Avvinity Therapeutics Limited Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Avvinity Therapeutics Limited?
Avvinity is developing novel immunotherapeutics targeted to cancer, harnessing a natural immune adaptation by humans and other primates.
keywords:N/AN/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Avvinity Therapeutics Limited News
2022-04-13 - ESMO Scale for Clinical Actionability of Molecular Targets ...
Treatment options for advanced cholangiocarcinoma are limited and ... expand therapeutic opportunities in a chemotherapy-refractory setting.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 11 | 0% | N/A |
#2 | $0.4M | 11 | 0% | $21.5M |
#3 | $1M | 11 | 0% | N/A |
#4 | $1M | 11 | N/A | N/A |
#5 | $1M | 11 | N/A | N/A |